1. Sarcoma after Radiation Therapy: Retrospective Multiinstitutional Study of 80 Histologically Confirmed Cases
- Author
-
P. Lagarde, Jean-Léon Lagrange, Sok Hun Seng, Brigitte de la Fontan, Pierre Richaud, Alain Ramaioli, Jacqueline Bof, P. Rambert, Christian Marchal, Jean-Pierre Ghnassia, Marie-Christine Chateau, Jean-Michel Coindre, Jacques Tortechaux, M. Reme-Saumon, and M. Resbeut
- Subjects
Cervical cancer ,medicine.medical_specialty ,Chemotherapy ,business.industry ,medicine.medical_treatment ,Soft tissue ,medicine.disease ,Lymphoma ,Surgery ,Radiation therapy ,Breast cancer ,medicine ,Radiology, Nuclear Medicine and imaging ,Sarcoma ,Complication ,business - Abstract
PURPOSE: To evaluate the best strategy for treatment of sarcoma that occurs after radiation therapy. MATERIALS AND METHODS: Records were retrospectively reviewed for 80 patients with a confirmed histologic diagnosis of sarcoma that occurred after radiation therapy performed during 1975–1995. The patients were treated for breast cancer (n = 33, 42%), non-Hodgkin lymphoma (n = 9, 11%), cervical cancer (n = 9, 11%), benign lesions (n = 4, 5%), or other tumors (n = 25, 31%). Sarcoma occurred after a mean latency of 12 years (range, 3-64 years), with most (70%) developing in the soft tissue. Treatment included surgery (28 patients), surgery and chemotherapy (18 patients), chemotherapy only (15 patients), and radiation therapy (14 patients). RESULTS: By the end of the study, 51 patients were dead, including 46 due to sarcoma. Median survival was 23 months. Overall survival rates at 2 and 5 years, respectively, were 69% and 39% for patients treated with surgery, 10% and 0% for those treated with chemotherapy, an...
- Published
- 2000
- Full Text
- View/download PDF